Jing R R - OmicsDI

Show results for

Unknown (1898)
Proteomics (270)
Transcriptomics (256)
Genomics (70)
Metabolomics (53)
Multiomics (13)
Models (2)
Other (2)

Organisms

Homo sapiens (348)
Mus musculus (84)
Rattus norvegicus (14)
Danio rerio (11)
Arabidopsis thaliana (10)
Macaca mulatta (6)
Saccharomyces cerevisiae (6)
Oryza sativa (4)
Solanum lycopersicum (4)
Drosophila melanogaster (4)
Severe acute respiratory syndrome coronavirus 2 (3)
Bradyrhizobium diazoefficiens USDA 110 (2)
Shewanella piezotolerans WP3 (2)
Yersinia pestis (2)
Sus scrofa (2)
Agrobacterium tumefaciens (1)
Brucella abortus str. 2308 A (1)
Nannochloropsis oceanica (1)
Helicoverpa zea (1)
Streptomyces bingchenggensis (1)
Candidatus Pelagibacter ubique HTCC1062 (1)
Populus tomentosa (1)
Populus x canadensis (1)
Arachis hypogaea (1)
Gossypium hirsutum (1)
Picea abies (1)
Streptococcus suis (1)
Medicago truncatula (1)
Citrus sinensis (1)
Brassica oleracea var. italica (1)

Organisms

Mus musculus (5)
Homo sapiens (1)
Danio rerio (1)

Repository

biostudies-arrayexpress (270)
PeptideAtlas (109)
iProX (65)
pride (50)
EGA (49)
MetaboLights (46)
MassIVE (40)
ENA (8)
GNPS (7)
BioModels (2)
GPMDB (2)
jPOST (2)
PAXDB (2)
PanoramaPublic (1)

Tissue

Digestive System (95)
Plasma Non-glyco (11)
Cell culture (10)
Epithelial cell (4)
Lung (4)
Others (3)
Blood cell (2)
Epithelial cell of lung (2)
Liver (2)
Ovary (2)
Plant cell (2)
Testis (2)
Blood (1)
Blood plasma (1)
Blood serum (1)
Bone marrow (1)
Breast cancer cell (1)
Cerebrospinal fluid (1)
Colonic mucosa (1)
Endometrial gland (1)
Endothelial cell of umbilical vein (1)
Epithelium of stomach (1)
Erythrocyte (1)
Heart (1)
Hepatocyte (1)
Leaf (1)
Oocyte (1)
Peripheral blood mononuclear cell (1)
Primary cell (1)
Salivary gland (1)

Disease

Breast cancer (3)
COVID-19 (2)
Not Available (2)
Chronic bronchitis (2)
Non-small cell lung carcinoma (2)
Acute myeloid leukemia (1)
Acute leukemia (1)
Bacterial sepsis (1)
Cardiovascular system disease (1)
Cervix carcinoma (1)
Disease free (1)
Irritable bowel syndrome (1)
Melanoma (1)
Oligospermia (1)
Polycystic ovary syndrome (1)
Pulmonary fibrosis (1)
Sjogren's Syndrome (1)
Stage IV colorectal cancer (1)
Stomach cancer (1)
Swine influenza (1)
Thanatophoric Dysplasia (1)
Trypanosomiasis (1)
Type 2 diabetes mellitus (1)
Wounds and Injuries (1)

Technology Type

Mass Spectrometry (50)
Mass spectrometry (28)
Shotgun proteomics (27)
Mass spectrometry assay (16)
Bottom-up proteomics (9)
Illumina HiSeq 2000 (4)
Affinity purification coupled with mass spectrometry proteomics (3)
Gel-based experiment (3)
SWATH MS (3)
NMR spectroscopy (2)
Affinity proteomics (2)
Data-independent acquisition (2)
Affymetrix_U133v2, Illumina HiSeq 2000 (1)
Illumina HiSeq 2000, Affymetrix SNP 6.0 (1)
Illumina HiSeq 2000, HiSeq X Ten, Illumina HiSeq 2500, ILLUMINA (1)
Data-dependent acquisition (1)
Immunopeptidomics (1)
Proteogenomics (1)
Top-down proteomics (1)

Instrument Platform

LTQ Orbitrap Velos (108)
Q Exactive (16)
Liquid Chromatography MS - positive - reverse phase (16)
Liquid Chromatography MS - negative - reverse phase (15)
TripleTOF 5600 (12)
Illumina HiSeq 4000 (9)
Liquid Chromatography MS - negative - reverse-phase (9)
Liquid Chromatography MS - positive - reverse-phase (6)
Liquid Chromatography MS - positive - hilic (5)
Illumina HiSeq 2500 (4)
Illumina HiSeq 2000 (4)
LTQ Orbitrap Elite (4)
Liquid Chromatography MS - negative - hilic (4)
NextSeq 500 (3)
Q Exactive HF (3)
MS:1000031 (3)
Orbitrap Fusion (3)
Liquid Chromatography MS - alternating - reverse-phase (3)
DELL PRECISION 7500 (2)
Retsch MM400 (2)
None (2)
Illumina NovaSeq 6000 (2)
TripleTOF 6600 (2)
Instrument (2)
Orbitrap Eclipse (2)
Orbitrap Fusion Lumos (2)
Illumina HiSeq 2000 platform (1)
HiSeq 2000 (1)
Illumina HiSeq 3000 (1)
LTQ (1)

Publication Date

2014 (138)
2012 (47)
2015 (41)
2024 (38)
2011 (33)
2026 (31)
2013 (31)
2022 (28)
2016 (27)
2025 (26)
2021 (24)
2023 (22)
2010 (22)
2020 (16)
2008 (13)
2017 (12)
2018 (10)
2009 (10)
2019 (9)
2007 (3)
2006 (2)
2004 (1)

UNIPROT ID/AC

1433B_SOYBN (2)
1433D_SOYBN (2)
6DCS_SOYBN (2)
A1YZE0_SOYBN (2)
A5I866_SOYBN (2)
A5JUQ4_SOYBN (2)
A5JVZ7_SOYBN (2)
A5Z2K3_SOYBN (2)
A7BIC9_SOYBN (2)
A7X657_SOYBN (2)
A7XZJ7_SOYBN (2)
A9CPA7_SOYBN (2)
A9QNE4_SOYBN (2)
ACCD_SOYBN (2)
ACT3_SOYBN (2)
AKR1_SOYBN (2)
AMYB_SOYBN (2)
AOX3_SOYBN (2)
ATPB_SOYBN (2)
ATPE_SOYBN (2)
ATPF_SOYBN (2)
B0M195_SOYBN (2)
B0M196_SOYBN (2)
B0M1A0_SOYBN (2)
B0M1A4_SOYBN (2)
B0M1A6_SOYBN (2)
B0M1A9_SOYBN (2)
B0M1B1_SOYBN (2)
B1ACD3_SOYBN (2)
B1ACD5_SOYBN (2)

ENSEMBL ID

ENSG00000170477 (107)
ENSG00000229353 (47)
ENSG00000147251 (22)
ENSG00000247315 (8)
ENSG00000176092 (2)

CHEBI ID

CHEBI:17368 (15)
CHEBI:17568 (12)
CHEBI:15756 (11)
CHEBI:16015 (11)
CHEBI:16704 (11)
CHEBI:16919 (11)
CHEBI:17154 (11)
CHEBI:17596 (11)
CHEBI:7916 (11)
CHEBI:15891 (10)
CHEBI:15971 (10)
CHEBI:16750 (10)
CHEBI:17053 (10)
CHEBI:17295 (10)
CHEBI:17895 (10)
CHEBI:18089 (10)
CHEBI:18344 (10)
CHEBI:16027 (9)
CHEBI:16359 (9)
CHEBI:17012 (9)
CHEBI:17405 (9)
CHEBI:17687 (9)
CHEBI:24813 (9)
CHEBI:28997 (9)
CHEBI:15753 (8)
CHEBI:16335 (8)
CHEBI:16347 (8)
CHEBI:16393 (8)
CHEBI:16543 (8)
CHEBI:16708 (8)

Metabolite Name

Hypoxanthine (16)
Creatine (14)
Taurine (13)
L-Tyrosine (12)
L-Phenylalanine (11)
Riboflavin (11)
Xanthine (11)
4-Pyridoxic acid (10)
Adenine (10)
Adenosine (10)
Choline (10)
Deoxycholic acid (10)
Inosine (10)
Kynurenic acid (10)
Uracil (10)
Uridine (10)
Azelaic acid (9)
Cholic acid (9)
Creatinine (9)
Guanine (9)
Guanosine (9)
Indole (9)
Taurocholic acid (9)
Thymidine (9)
4-Hydroxybenzaldehyde (8)
Cytidine (8)
Deoxyinosine (8)
L-Histidine (8)
L-Threonine (8)
N-Acetylneuraminic acid (8)

First Public Date

2026 (2)
2024 (1)
2023 (1)
2022 (1)
2020 (1)
2019 (1)
2014 (1)

Modelling Approach

Population model (2)

Lab affiliation

National Center for Protein Science Beijing (2)
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, Guangdong, P.R. China. (2)
Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2)
State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu,China. (2)
Acupuncture-moxibustion and Orthopedic College, Hubei University of Chinese Medicine, Wuhan, China (1)
Analytical Research Center for Organic and Biological Molecules, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China (1)
Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS) Technische Universität München (TUM) Gregor-Mendel-Straße 4 85354 Freising GERMANY (1)
Beijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China (1)
Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China; (1)
Center of Reproductive Medicine, Nanjing Jinling Hospital, Clinical School of Medical College, Nanjing University, China. (1)
Chinese Academy of Inspection and Quarantine (1)
Dalian Medical University (1)
Department of Analytical Chemistry and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (1)
Department of Biology, Washington University in St. Louis (1)
Department of Critical Care Medicine, Nanjing Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, People's Republic of China. (1)
Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China (1)
Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, People’s Republic of China (1)
Department of Laboratory Medicine & Central Laboratory, Southern Medical University Affiliated Fengxian Hospital, China. (1)
Department of Medicine, University of Cape Town & Groote Schuur Hospital, Cape Town, South Africa (1)
Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin (1)
Department of Orthopaedics, Peking University Third Hospital (1)
Department of Pathology (1)
Department of Reproductive Medicine, Affiliated Jinling Hospital , Nanjing Medical University (1)
Department of Thyroid and Breast Surgery, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China (1)
Fudan University, Huashan Hospital (1)
Harbin Medical University (1)
Hubei University of Technology (1)
Human Immunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Department of Health and Human Services, Unites States Government (1)
Institute of Mechanobiology and Medical Engineering School of Life Sciences and Biotechnology Shanghai Jiao Tong University Shanghai China (1)
Institute of dermatology, Chinese academy of medical sciences (1)

IsPrivate

False (2)

Submitter Keywords

COVID-19 (2)

Study type

Transcription profiling by array (178)
RNA-seq of coding RNA (33)
ChIP-seq (10)
RNA-seq of non coding RNA (9)
Comparative genomic hybridization by array (6)
ChIP-chip by tiling array (4)
Transcription profiling by RT-PCR (4)
Other (4)
Animal - High-throughput sequencing (3)
RIP-seq (3)
Human - Methylation microarray (2)
MicroRNA profiling by array (2)
Methylation profiling by high throughput sequencing (2)
Transcription profiling by SAGE (1)
Unknown experiment type (1)
Human - High-throughput sequencing (1)
Transcription profiling by tiling array (1)
ChIP-chip by array (1)
Genotyping by array (1)
DNA-seq (1)
Methylation profiling by array (1)
Proteomic profiling by array (1)
RNA-seq of total RNA (1)

Release Date

2025 (300)
2023 (252)
2022 (234)
2024 (229)
2021 (189)
2020 (151)
2019 (95)
2016 (94)
2015 (87)
2018 (79)
2014 (79)
2012 (67)
2017 (65)
2011 (65)
2013 (54)
2026 (40)
2010 (39)
2008 (17)
2009 (15)
2007 (5)
2006 (4)
2005 (3)
2004 (1)
2003 (1)
2002 (1)
2000 (1)

Previous page
1 / 256
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 256
Next page

Sort by:

Relevance

Page size

Mechanism of terpene formation in Pogostemon cablin cv. Jing Huoxiang revealed by metabolome and transcriptome analysis

Pogostemon cablin (Blanco) Benth. cv. 'Jing Huoxiang', is a valuable medicinal plant widely studied for its aboveground tissues, which are rich in bioactive compounds such as patchouli alcohol. However, systematic investigations into the biosynthesis of sesquiterpenes in its underground parts (ro...

2025-10-12 | MTBLS13122 | MetaboLights

Genome-wide R-loop landscapes during epigenetic programming and reprogramming

PRJNA608890 | ENA

Progesterone improved the behavior of PC12 cells under OGD/R by reducing FABP5 expression and inhibiting TLR4/NF-κB signaling pathway.

Not available

S-EPMC10995011 | biostudies-literature

Selective Permeability of Mouse Blood-Aqueous Barrier as Determined by 15N-Heavy Isotope Tracing and Mass Spectrometry

Pan Liu , Benjamin R. Thomson , Natalia Khalatyan , Liang Feng , Xiaorong Liu , Jeffrey N Savas , Susan E. Quaggin , Jing Jin

ORGANISM(S): Mus Musculus (ncbitaxon:10090)

2018-07-10 | MSV000082590 | MassIVE

A genome-wide single nucleotide polymorphism scan reveals genetic markers associated with fertility rate in Chinese Jing Hong chicken.

Not available

S-EPMC7597651 | biostudies-literature

Simulating highly disturbed vegetation distribution: the case of China's Jing-Jin-Ji region.

Not available

S-EPMC7474518 | biostudies-literature

SIRT6 regulates Ras-related protein R-Ras2 by lysine defatty-acylation.

Not available

S-EPMC5391209 | biostudies-literature

TRIM28 is an E3 ligase of IRP2 suppressing ischemia/reperfusion-induced myocardial ferroptosis

Myocardial ischemia/reperfusion (I/R) injury is a common and severe clinical complication in patients with ischemic heart disease (IHD) after reperfusion therapy. Effective therapeutic strategies for myocardial I/R injury remain limited. Ferroptosis is a form of regulated cell death characterized by...

ORGANISM(S): Rattus Norvegicus

2025-12-28 | PXD072478 |

The oncometabolite R-2-hydroxyglutarate inhibits microglial activation via the FTO/NF-κB pathway.

Not available

S-EPMC12683333 | biostudies-literature

Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE.

Not available

S-EPMC11512864 | biostudies-literature

Previous page
1 / 256
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 256
Next page

Sort by:

Relevance

Page size

2551 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

ENSEMBL ID

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Lab affiliation

Tags

IsPrivate

Submitter Keywords

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets